TME Pharma N.V. (ALTME) — Financial Flexibility Index
TME Pharma N.V. (ALTME) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of €-557.00K (operating CF €-557.00K minus capex €0.00) represents 0% of total liabilities (€3.72 Million). Check ALTME intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TME Pharma N.V. Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for TME Pharma N.V. across 12 annual periods. For the full cash flow conversion analysis, see ALTME cash generation efficiency.
Annual Financial Flexibility Index for TME Pharma N.V. (2014–2025)
Year-by-year free cash flow to debt coverage for TME Pharma N.V.. Explore TME Pharma N.V. (ALTME) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.92x | €-3.42 Million | €-3.42 Million | €3.72 Million | ▲ +64.3% |
| 2024 | -2.58x | €-4.62 Million | €-4.63 Million | €1.79 Million | ▼ -27.8% |
| 2023 | -2.02x | €-5.62 Million | €-5.63 Million | €2.79 Million | ▼ -8.3% |
| 2022 | -1.86x | €-12.12 Million | €-12.14 Million | €6.51 Million | ▲ +20.7% |
| 2021 | -2.35x | €-12.37 Million | €-12.38 Million | €5.27 Million | ▼ -33.9% |
| 2020 | -1.75x | €-5.18 Million | €-5.22 Million | €2.96 Million | ▼ -47.3% |
| 2019 | -1.19x | €-4.27 Million | €-4.29 Million | €3.59 Million | ▼ -112.6% |
| 2018 | -0.56x | €-3.99 Million | €-4.00 Million | €7.12 Million | ▲ +35.9% |
| 2017 | -0.87x | €-4.24 Million | €-4.24 Million | €4.85 Million | ▲ +47.9% |
| 2016 | -1.68x | €-8.97 Million | €-8.99 Million | €5.35 Million | ▼ -62.6% |
| 2015 | -1.03x | €-13.47 Million | €-13.48 Million | €13.07 Million | ▲ +22.5% |
| 2014 | -1.33x | €-12.41 Million | €-12.46 Million | €9.33 Million | — |